Spirecut, a Muttenz-based medtech start-up, is revolutionizing hand surgery with a groundbreaking ultrasound-guided technique spearheaded by CEO Frédéric Schuind. Moving away from traditional incision-based methods, Spirecut’s innovation requires a minor puncture to treat common hand disorders such as trigger finger and carpal tunnel syndrome.”
Continue readingSpirecut’s Training with KOLs
On Friday, June 23rd, Spirecut hosted a training session at Sitem-insel AG, located in Bern, Switzerland. The session primarily focused on the ultrasound-guided percutaneous surgical treatments of two prevalent hand conditions: trigger fingers and carpal tunnel syndrome. Participants included future Key Opinion Leaders (KOLs).
Continue readingSpirecut is the Inaugural Start-up Partner of the Global Nerve Foundation
Spirecut has recently joined the Global Nerve Foundation (GNF) as its first-ever Start-up Partner. GNF is an organization dedicated to the betterment of individuals with nerve-related conditions globally.
This partnership resonates with Spirecut’s mission to enhance patient outcomes through ultrasound guidance. The congruity of our visions makes this collaboration a step forward in the direction of patient care enhancement.
Spirecut CEO Discusses Advances in Hand Surgery on X-Health.show Podcast
Prof Frédéric Schuind, Spirecut’s founder and CEO, recently participated in the X-Health.show podcast. The discussion centered around the latest breakthroughs in hand surgery, with a particular emphasis on trigger finger and carpal tunnel syndrome treatments.
Continue readingSpirecut attends FESSH 2023 in Rimini, Italy
Spirecut marked its presence at the Federation of European Societies for the Surgery of the Hand (FESSH) conference. Professor Moungondo demonstrated our ultrasound-guided technique for treating trigger finger and carpal tunnel syndrome.
Continue readingSpirecut’s European patent is officially approved
Spirecut’s European patent has been officially approved. This represents a significant milestone for our company as it reinforces our intellectual property portfolio. This development will enable us to expand our solutions across Europe, fostering innovation and enhancing healthcare in the region.
Continue readingSpirecut’s Successful Clinical Study with Archer Research
The study involved 30 adult participants, equally divided between the two conditions under investigation. One of the critical aspects of this research was the assessment of safety, gauged by the number of severe peri- and post-operative adverse events.
Continue readingSpirecut at Swiss Startup Days
Representatives from Spirecut (Clémence Hermann, and Edmond Sula) recently attended Startup Days (SUD), Switzerland’s premier startup conference, providing insights into our innovative solutions and opportunities for meaningful discussions and partnerships.
Continue readingSpirecut at the Joint Meeting of ASSH & ISHS
The Spirecut team recently attended the joint meeting of the American Society for Surgery of the Hand and the Israeli Society of Hand Surgery. This joint meeting brought together experts from across the globe to share insights and advancements in hand surgery.
Continue reading